Prof Tacke, Germany reviews the epidemiological challenge of NAFLD and NASH worldwide, especially with the obesity pandemic. He describes the clinical impact of inflammation and fibrosis in NAFLD and the role of macrophages. Finally, he discusses the possible therapeutic implications. Credit : 4th global NASH congress 2021

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In

3 + 20 =